2011
DOI: 10.1503/cjs.014010
|View full text |Cite
|
Sign up to set email alerts
|

Total pelvic exenteration for rectal cancer: outcomes and prognostic factors

Abstract: Background:To perform complete resection of locally advanced and recurrent rectal carcinoma, total pelvic exenteration (TPE) may be attempted. We identified disease-related outcomes and prognostic factors. Methods:We conducted a single-centre review of patients who underwent TPE for rectal carcinoma over a 10-year period. Results:We included 28 patients in our study. After a median follow-up of 35 months, 53.6% of patients were alive with no evidence of disease. The 3-year actuarial disease-free and overall su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
27
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 33 publications
(32 citation statements)
references
References 43 publications
(37 reference statements)
4
27
1
Order By: Relevance
“…The perioperative mortality following TPE has decreased from as high as 20 % before 2000 [9,10] to less than 5 % in recently reported case series [7,11,12]. In the present series, one operative death was noted in the earlier period, but there Fig.…”
Section: Discussioncontrasting
confidence: 52%
See 3 more Smart Citations
“…The perioperative mortality following TPE has decreased from as high as 20 % before 2000 [9,10] to less than 5 % in recently reported case series [7,11,12]. In the present series, one operative death was noted in the earlier period, but there Fig.…”
Section: Discussioncontrasting
confidence: 52%
“…In recent reports, postoperative complication rates after TPE for primary tumors have been reported to range from 26 % [11] to 68 % [12]; the present series did not show a high rate of postoperative complications. Pathologically curative resection (R0) was achieved in 96 % of cases, which was no worse than reported in recent years, as 66 % [13], 71 % [12], and 75 % [7].…”
Section: Discussionmentioning
confidence: 63%
See 2 more Smart Citations
“…Reviewing the latest studies regarding pelvic exenteration for recurrent rectal cancer the mortality varied between 0 and 13% [6][7][8][9][10][11][12][13]. Late oncological results showed a 5-year survival between 14 and 27% [9,12].…”
Section: Discussionmentioning
confidence: 99%